- Home
- DTST vs RADX Comparison
DTST vs RADX Comparison
Compare DTST & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- RADX
- Stock Information
- Founded
- DTST 2001
- RADX 2021
- Country
- DTST United States
- RADX Australia
- Employees
- DTST N/A
- RADX N/A
- Industry
- DTST EDP Services
- RADX
- Sector
- DTST Technology
- RADX
- Exchange
- DTST Nasdaq
- RADX NYSE
- Market Cap
- DTST 28.2M
- RADX 32.5M
- IPO Year
- DTST N/A
- RADX N/A
- Fundamental
- Price
- DTST $3.41
- RADX $4.70
- Analyst Decision
- DTST
- RADX Strong Buy
- Analyst Count
- DTST 0
- RADX 2
- Target Price
- DTST N/A
- RADX $13.50
- AVG Volume (30 Days)
- DTST 34.4K
- RADX 21.1K
- Earning Date
- DTST 08-13-2025
- RADX 02-26-2025
- Dividend Yield
- DTST N/A
- RADX N/A
- EPS Growth
- DTST N/A
- RADX N/A
- EPS
- DTST 0.02
- RADX N/A
- Revenue
- DTST $25,219,312.00
- RADX $204,609.00
- Revenue This Year
- DTST $12.57
- RADX N/A
- Revenue Next Year
- DTST $9.29
- RADX N/A
- P/E Ratio
- DTST $142.68
- RADX N/A
- Revenue Growth
- DTST N/A
- RADX N/A
- 52 Week Low
- DTST $2.93
- RADX $3.50
- 52 Week High
- DTST $6.95
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- DTST 41.10
- RADX N/A
- Support Level
- DTST $3.34
- RADX N/A
- Resistance Level
- DTST $3.48
- RADX N/A
- Average True Range (ATR)
- DTST 0.18
- RADX 0.00
- MACD
- DTST -0.03
- RADX 0.00
- Stochastic Oscillator
- DTST 21.92
- RADX 0.00
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.